Addition of Statins to Treatment With β-Blockers to Improve Outcomes for Cardiac Surgery Patients: Beyond the Surgical Care Improvement Project

JAMA Surg. 2016 Apr;151(4):389-91. doi: 10.1001/jamasurg.2015.4212.

Authors

William Toppen¹, Sohail Sareh¹, Daniel Johansen¹, Bradley Genovese, Nancy Satou¹, Richard Shemin¹, Peyman Benharash¹

Affiliation

¹ Division of Cardiac Surgery, David Geffen School of Medicine at University of California, Los Angeles.

PMID: 26580138
DOI: 10.1001/jamasurg.2015.4212

No abstract available

MeSH terms

Adrenergic beta-Antagonists / therapeutic use*
Aged
California / epidemiology
Cardiac Surgical Procedures*
Drug Therapy, Combination
Female
Follow-Up Studies
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Incidence
Male
Middle Aged
Perioperative Care / methods*
Postoperative Complications / epidemiology
Postoperative Complications / prevention & control*
Quality Improvement*
Retrospective Studies
Survival Rate / trends
Treatment Outcome

Substances

Adrenergic beta-Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors